The emergence and takeover of hepatitis B virus (HBV) variants carrying mutation (s) in the
preS/S genomic region is a fairly frequent event that may occur spontaneously or may be the …

Hepatitis B virus has been evolving gradually over a long period of time, resulting in a large
amount of genetic diversity, despite the constraints imposed by the complex genetic …

Hepatitis B virus (HBV) infection is a major public health problem in many countries, with
nearly 300 million people worldwide carrying HBV chronic infection and over 1 million …

Hepatitis B viral mutants can emerge in patients as a result of selection pressure from either
immune response or treatment options. Mutations that occur within the immunodominant …

Hepatitis B virus (HBV) is a human DNA virus, which replicates through an RNA
intermediate because of the reverse‐transcriptase (RT) activity of its DNA polymerase. As a …

Background & Aims HBV immune escape represents a challenge to prevention, diagnosis,
and treatment of hepatitis B. Here, we analyzed the molecular and clinical characteristics of …

Human hepatitis B virus (HBV) is a hepatotropic virus that is responsible for a significant
burden of disease, causing liver disease and hepatocellular carcinoma. It is a small DNA …

Hepatitis B virus (HBV) is a DNA virus with complex replication, and high replication and
mutation rates, leading to a heterogeneous viral population. The population is comprised of …

The hepatitis B virus (HBV) is a global public health problem with more than 240 million
people chronically infected worldwide, who are at risk for end-stage liver disease and …

Background. Mutants of the a determinant of hepatitis B surface antigen (HBsAg) can
escape neutralization by vaccine-induced antibodies and prevail in an immunized …